Published in Rev Infect Dis on April 12, 1989
Plasmid transfer from Escherichia coli to Bacteroides fragilis: differential expression of antibiotic resistance phenotypes. Proc Natl Acad Sci U S A (1984) 3.85
Conjugative transfer of multiple antibiotic resistance markers in Streptococcus pneumoniae. J Bacteriol (1980) 2.63
Tetracycline-inducible transfer of tetracycline resistance in Bacteroides fragilis in the absence of detectable plasmid DNA. J Bacteriol (1982) 1.10
Plasmid analyses in clinical isolates of Bacteroides fragilis and other Bacteroides species. J Clin Microbiol (1981) 0.90
Stability in Escherichia coli of an antibiotic resistance plasmid from Bacteroides fragilis. J Bacteriol (1981) 0.81
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 5.65
Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell (2000) 3.65
Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature (1985) 3.38
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80
Immunophysiology of experimental food allergy. Mucosal Immunol (2008) 2.76
Bulgeless dwarf galaxies and dark matter cores from supernova-driven outflows. Nature (2010) 2.71
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology (2002) 2.52
Massive outbreak of antimicrobial-resistant salmonellosis traced to pasteurized milk. JAMA (1987) 2.47
Human T cell hybridomas secreting factors for IgA-specific help, polyclonal B cell activation, and B cell proliferation. J Exp Med (1982) 2.27
Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol (1997) 1.80
Molecular cloning of pertussis toxin genes. Nucleic Acids Res (1986) 1.64
Human malignant T cells capable of inducing an immunoglobulin class switch. J Exp Med (1985) 1.56
CXCL13 expression in the gut promotes accumulation of IL-22-producing lymphoid tissue-inducer cells, and formation of isolated lymphoid follicles. Mucosal Immunol (2009) 1.39
Persistent infection of human adenovirus type 5 in human monocyte cell lines. Virology (1992) 1.34
CD1d is involved in T cell-intestinal epithelial cell interactions. J Exp Med (1993) 1.31
Interleukin 6 induces secretion of IgG1 by coordinated transcriptional activation and differential mRNA accumulation. Proc Natl Acad Sci U S A (1989) 1.30
The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells. J Immunol (1998) 1.29
Evidence for a defect in "switch" T cells in patients with immunodeficiency and hyperimmunoglobulinemia M. N Engl J Med (1986) 1.29
Gastrointestinal manifestations of primary immunodeficiency disorders. Semin Gastrointest Dis (1997) 1.25
Treatment of intractable gastrointestinal manifestations of chronic granulomatous disease with cyclosporine. J Pediatr (1995) 1.23
Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors. J Clin Invest (1984) 1.23
Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin Ther (1996) 1.21
FURTHER STUDIES IN OSTEOGENESIS. Ann Surg (1919) 1.19
Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses (1993) 1.17
T-cell activation in human intestinal mucosa: the role of superantigens. Gastroenterology (1993) 1.16
Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology (1981) 1.16
Evidence for accessory cell function by class II MHC antigen-expressing airway epithelial cells. Am J Respir Cell Mol Biol (1991) 1.14
Stimulation of lamina propria lymphocytes by intestinal epithelial cells: evidence for recognition of nonclassical restriction elements. J Exp Med (1994) 1.14
Immunoregulatory lymphokines of T hybridomas from AIDS patients: constitutive and inducible suppressor factors. Science (1984) 1.14
Regulation of interleukin 6 receptor expression in human monocytes and monocyte-derived macrophages. Comparison with the expression in human hepatocytes. J Exp Med (1989) 1.13
Pasteurization of milk proteins promotes allergic sensitization by enhancing uptake through Peyer's patches. Allergy (2008) 1.09
Synthesis and regulation of accessory/proinflammatory cytokines by intestinal epithelial cells. Clin Exp Immunol (1995) 1.06
Interleukins 1 and 3 stimulate anion secretion in chicken intestine. Gastroenterology (1990) 1.04
Selective regulation of cytokine secretion by hydroxychloroquine: inhibition of interleukin 1 alpha (IL-1-alpha) and IL-6 in human monocytes and T cells. J Rheumatol (1993) 1.04
Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer. J Clin Oncol (1999) 1.02
Human intestinal epithelial cell-induced CD8+ T cell activation is mediated through CD8 and the activation of CD8-associated p56lck. J Exp Med (1995) 1.02
Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease. J Clin Invest (1997) 1.02
The role of epithelial cells in immune regulation in the gut. Semin Immunol (2001) 1.01
CD5 and immunoglobulin V gene expression in B-cell lymphomas and chronic lymphocytic leukemia. Blood (1990) 1.00
Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis (2000) 0.98
High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. Pharmacogenetics (1998) 0.97
The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium. Autoimmunity (1991) 0.97
Terminal maturation of resting B cells by proliferation-independent B cells differentiation factors. J Exp Med (1986) 0.97
Purification and in vitro growth of human epidermal basal keratinocytes using a monoclonal antibody. J Invest Dermatol (1985) 0.97
Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages. Biochim Biophys Acta (2001) 0.96
Malignant degeneration of so-called benign osteoblastoma. Bull Hosp Joint Dis (1967) 0.96
Suppression of Th1 and Th17, but not Th2, responses in a CD8(+) T cell-mediated model of oral tolerance. Mucosal Immunol (2009) 0.94
A single-arm, open-label study of alemtuzumab in treatment-refractory patients with multiple sclerosis. Eur J Neurol (2011) 0.94
Insulin action on glucose uptake into skeletal muscle: inhibition of endogenous biosynthesis of prostaglandins. FEBS Lett (1978) 0.93
Identification of subpopulations of human macrophages through the generation of human macrophage hybridomas. J Immunol Methods (1990) 0.93
Characterization of a 180-kDa intestinal epithelial cell membrane glycoprotein, gp180. A candidate molecule mediating t cell-epithelial cell interactions. J Biol Chem (1997) 0.92
Analysis of the attachment and invasion of human epithelial cells by Haemophilus influenzae biogroup aegyptius. J Infect Dis (1992) 0.91
IgA specific T-cell factor produced by a human T-T hybridoma. Ann N Y Acad Sci (1983) 0.90
The motor agitation and retardation scale: a scale for the assessment of motor abnormalities in depressed patients. J Neuropsychiatry Clin Neurosci (1998) 0.90
Cytokine secretion induced by superantigens in peripheral blood mononuclear cells, lamina propria lymphocytes, and intraepithelial lymphocytes. Clin Diagn Lab Immunol (1995) 0.89
Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel. Anticancer Drugs (1997) 0.89
Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease. Dig Dis Sci (1995) 0.89
Acute yersinial ileitis: a distinct entity. Am J Gastroenterol (1976) 0.89
The intestinal epithelial cell: processing and presentation of antigen to the mucosal immune system. Immunol Rev (1999) 0.88
Interactions between peripheral blood CD8 T lymphocytes and intestinal epithelial cells (iEC). Clin Exp Immunol (1998) 0.88
Association of the GABRD gene and childhood-onset mood disorders. Genes Brain Behav (2010) 0.88
The IBD1 locus for susceptibility to Crohn's disease has a greater impact in Ashkenazi Jews with early onset disease. Am J Gastroenterol (2001) 0.88
Inhibition of HIV-1 productive infection in hepatoblastoma HepG2 cells by recombinant tumor necrosis factor-alpha. AIDS (1992) 0.86
Cytokine Genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disorders. Neuropsychobiology (2008) 0.86
Characterization of the T cell receptor repertoire in patients with common variable immunodeficiency: oligoclonal expansion of CD8(+) T cells. Clin Immunol (2000) 0.86
In vitro induction of T cell-dependent B cell differentiation in patients with common varied immunodeficiency. Clin Immunol Immunopathol (1988) 0.86
Diagnosis and treatment of primary immunodeficiency disease in patients with gastrointestinal symptoms. Clin Immunol (2011) 0.85
T-cell subsets in multiple sclerosis: lack of correlation between helper and suppressor T cells and the clinical state. J Clin Immunol (1985) 0.85
A non-class I MHC intestinal epithelial surface glycoprotein, gp180, binds to CD8. Clin Immunol (2002) 0.85
Brief report: enhanced humoral immunity in common variable immunodeficiency after long-term treatment with polyethylene glycol-conjugated interleukin-2. N Engl J Med (1994) 0.85
Progressive impairment of monocytic function in HIV-1-infected human macrophage hybridomas. AIDS Res Hum Retroviruses (1993) 0.84
Expression of protooncogene-encoded mRNA by colonic epithelial cells in inflammatory bowel disease. Dig Dis Sci (1996) 0.84
Restoration of immunoglobulin secretion in vitro in common variable immunodeficiency by in vivo treatment with polyethylene glycol-conjugated human recombinant interleukin-2. Clin Immunol Immunopathol (1992) 0.84
Mucus secretagogue production by a human macrophage hybridoma. J Allergy Clin Immunol (1991) 0.84
Regulation of B cell activation and differentiation with factors generated by human T cell hybridomas. Immunol Rev (1984) 0.84
Impairment of monocytic function during Trypanosoma cruzi infection. Clin Diagn Lab Immunol (1994) 0.83
Factors affecting antigen uptake by human intestinal epithelial cell lines. Dig Dis Sci (2000) 0.83
Increase of out-of-hospital cardiac arrests in the male population of the French speaking provinces of Switzerland during the 1998 FIFA World Cup. Heart (2005) 0.83
Differential expression of interleukin 1 receptor antagonist isoforms in human intestinal epithelial cells. Gastroenterology (1998) 0.83
Extended haplotype association study in Crohn's disease identifies a novel, Ashkenazi Jewish-specific missense mutation in the NF-κB pathway gene, HEATR3. Genes Immun (2013) 0.83
Lung function in retired coke oven plant workers. Br J Ind Med (1992) 0.83
The nonclassical class I molecule CD1d associates with the novel CD8 ligand gp180 on intestinal epithelial cells. J Biol Chem (1999) 0.83
Evidence for an involvement of kinin liberation in the priming action of insulin on glucose uptake into skeletal muscle. FEBS Lett (1979) 0.82
Correlation of clinical parameters and immunological function with human immunodeficiency virus plasma viremia in children. Viral Immunol (1999) 0.82
Umbilical cord blood serosurvey for human immunodeficiency virus in parturient women in a voluntary hospital in New York City. Obstet Gynecol (1989) 0.82
Antigen uptake and trafficking in human intestinal epithelial cells. Dig Dis Sci (2000) 0.82
IL-13-mediated immunological control of enterochromaffin cell hyperplasia and serotonin production in the gut. Mucosal Immunol (2012) 0.81
Lidocaine inhibits secretion of IL-8 and IL-1beta and stimulates secretion of IL-1 receptor antagonist by epithelial cells. Clin Exp Immunol (2002) 0.81
Attenuation of TNF-driven murine ileitis by intestinal expression of the viral immunomodulator CrmD. Mucosal Immunol (2010) 0.81
Bradykinin and human forearm metabolism: inhibition of endogenous prostaglandin synthesis. Hoppe Seylers Z Physiol Chem (1978) 0.81
Immunologic effects of low-dose polyethylene glycol-conjugated recombinant human interleukin-2 in common variable immunodeficiency. J Interferon Cytokine Res (1995) 0.81
Heterogeneity of B cell growth and differentiation factors. Lymphokine Res (1984) 0.80
Anti-benzo[a]pyrene diolepoxide--DNA adduct levels in peripheral mononuclear cells from coke oven workers and the enhancing effect of smoking. Carcinogenesis (1995) 0.80
Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. Proc Natl Acad Sci U S A (1995) 0.80
Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells. J Immunol (1989) 0.80
Lidocaine/tetracaine patch (Rapydan) for topical anaesthesia before arterial access: a double-blind, randomized trial. Br J Anaesth (2012) 0.79